Nucleic Acid Labeling Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Nucleic Acid Labeling Market, By Product Type

7.1.  Nucleic Acid Labeling Market, By Product Type, 2020-2030

7.1.1.    Kits

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Reagents

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Instruments

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Nucleic Acid Labeling Market, By Labeling Type

8.1.  Nucleic Acid Labeling Market, By Labeling Type, 2020-2030

8.1.1.    Radioisotope/Radioactive Labels

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Non-radioactive Labels

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Nucleic Acid Labeling Market, By Method Type

9.1.  Nucleic Acid Labeling Market, By Method Type, 2020-2030

9.1.1.    Enzyme-based

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Chemical-based

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Nucleic Acid Labeling Market, By Application Type

10.1.        Nucleic Acid Labeling Market, By Application Type, 2020-2030

10.1.1.  Oligonucleotide Labeling

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  In-situ Hybridization

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Southern & Northern Blotting

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Cellular Localization

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Others

10.1.5.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Nucleic Acid Labeling Market, By Sector Type

11.1.        Nucleic Acid Labeling Market, By Sector, 2020-2030

11.1.1.  Diagnostics

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Research

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Therapeutics

11.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Nucleic Acid Labeling  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product Type (2016-2030)

12.1.2.  Market Revenue and Forecast, By Labeling Type (2016-2030)

12.1.3.  Market Revenue and Forecast, By Method (2016-2030)

12.1.4.  Market Revenue and Forecast, By Application (2016-2030)

12.1.5.  Market Revenue and Forecast, By Sector (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.1.6.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.1.6.3.      Market Revenue and Forecast, By Method (2016-2030)

12.1.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.1.7.  Market Revenue and Forecast, By Sector (2016-2030)

12.1.8.  Rest of North America

12.1.8.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.1.8.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.1.8.3.      Market Revenue and Forecast, By Method (2016-2030)

12.1.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.1.8.5.      Market Revenue and Forecast, By Sector (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product Type (2016-2030)

12.2.2.  Market Revenue and Forecast, By Labeling Type (2016-2030)

12.2.3.  Market Revenue and Forecast, By Method (2016-2030)

12.2.4.  Market Revenue and Forecast, By Application (2016-2030)

12.2.5.  Market Revenue and Forecast, By Sector (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.2.6.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.2.6.3.      Market Revenue and Forecast, By Method (2016-2030)

12.2.7.  Market Revenue and Forecast, By Application (2016-2030)

12.2.8.  Market Revenue and Forecast, By Sector (2016-2030)

12.2.9.  Germany

12.2.9.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.2.9.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.2.9.3.      Market Revenue and Forecast, By Method (2016-2030)

12.2.10.               Market Revenue and Forecast, By Application (2016-2030)

12.2.11.               Market Revenue and Forecast, By Sector (2016-2030)

12.2.12.               France

12.2.12.1.   Market Revenue and Forecast, By Product Type (2016-2030)

12.2.12.2.   Market Revenue and Forecast, By Labeling Type (2016-2030)

12.2.12.3.   Market Revenue and Forecast, By Method (2016-2030)

12.2.12.4.   Market Revenue and Forecast, By Application (2016-2030)

12.2.13.               Market Revenue and Forecast, By Sector (2016-2030)

12.2.14.               Rest of Europe

12.2.14.1.   Market Revenue and Forecast, By Product Type (2016-2030)

12.2.14.2.   Market Revenue and Forecast, By Labeling Type (2016-2030)

12.2.14.3.   Market Revenue and Forecast, By Method (2016-2030)

12.2.14.4.   Market Revenue and Forecast, By Application (2016-2030)

12.2.15.               Market Revenue and Forecast, By Sector (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product Type (2016-2030)

12.3.2.  Market Revenue and Forecast, By Labeling Type (2016-2030)

12.3.3.  Market Revenue and Forecast, By Method (2016-2030)

12.3.4.  Market Revenue and Forecast, By Application (2016-2030)

12.3.5.  Market Revenue and Forecast, By Sector (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.3.6.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.3.6.3.      Market Revenue and Forecast, By Method (2016-2030)

12.3.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.3.7.  Market Revenue and Forecast, By Sector (2016-2030)

12.3.8.  China

12.3.8.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.3.8.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.3.8.3.      Market Revenue and Forecast, By Method (2016-2030)

12.3.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.3.9.  Market Revenue and Forecast, By Sector (2016-2030)

12.3.10.               Japan

12.3.10.1.   Market Revenue and Forecast, By Product Type (2016-2030)

12.3.10.2.   Market Revenue and Forecast, By Labeling Type (2016-2030)

12.3.10.3.   Market Revenue and Forecast, By Method (2016-2030)

12.3.10.4.   Market Revenue and Forecast, By Application (2016-2030)

12.3.10.5.   Market Revenue and Forecast, By Sector (2016-2030)

12.3.11.               Rest of APAC

12.3.11.1.   Market Revenue and Forecast, By Product Type (2016-2030)

12.3.11.2.   Market Revenue and Forecast, By Labeling Type (2016-2030)

12.3.11.3.   Market Revenue and Forecast, By Method (2016-2030)

12.3.11.4.   Market Revenue and Forecast, By Application (2016-2030)

12.3.11.5.   Market Revenue and Forecast, By Sector (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product Type (2016-2030)

12.4.2.  Market Revenue and Forecast, By Labeling Type (2016-2030)

12.4.3.  Market Revenue and Forecast, By Method (2016-2030)

12.4.4.  Market Revenue and Forecast, By Application (2016-2030)

12.4.5.  Market Revenue and Forecast, By Sector (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.4.6.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.4.6.3.      Market Revenue and Forecast, By Method (2016-2030)

12.4.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.4.7.  Market Revenue and Forecast, By Sector (2016-2030)

12.4.8.  North Africa

12.4.8.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.4.8.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.4.8.3.      Market Revenue and Forecast, By Method (2016-2030)

12.4.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.4.9.  Market Revenue and Forecast, By Sector (2016-2030)

12.4.10.               South Africa

12.4.10.1.   Market Revenue and Forecast, By Product Type (2016-2030)

12.4.10.2.   Market Revenue and Forecast, By Labeling Type (2016-2030)

12.4.10.3.   Market Revenue and Forecast, By Method (2016-2030)

12.4.10.4.   Market Revenue and Forecast, By Application (2016-2030)

12.4.10.5.   Market Revenue and Forecast, By Sector (2016-2030)

12.4.11.               Rest of MEA

12.4.11.1.   Market Revenue and Forecast, By Product Type (2016-2030)

12.4.11.2.   Market Revenue and Forecast, By Labeling Type (2016-2030)

12.4.11.3.   Market Revenue and Forecast, By Method (2016-2030)

12.4.11.4.   Market Revenue and Forecast, By Application (2016-2030)

12.4.11.5.   Market Revenue and Forecast, By Sector (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product Type (2016-2030)

12.5.2.  Market Revenue and Forecast, By Labeling Type (2016-2030)

12.5.3.  Market Revenue and Forecast, By Method (2016-2030)

12.5.4.  Market Revenue and Forecast, By Application (2016-2030)

12.5.5.  Market Revenue and Forecast, By Sector (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.5.6.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.5.6.3.      Market Revenue and Forecast, By Method (2016-2030)

12.5.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.5.7.  Market Revenue and Forecast, By Sector (2016-2030)

12.5.8.  Rest of LATAM

12.5.8.1.      Market Revenue and Forecast, By Product Type (2016-2030)

12.5.8.2.      Market Revenue and Forecast, By Labeling Type (2016-2030)

12.5.8.3.      Market Revenue and Forecast, By Method (2016-2030)

12.5.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.5.8.5.      Market Revenue and Forecast, By Sector (2016-2030)

Chapter 13.  Company Profiles

13.1.              PerkinElmer, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              F. Hoffmann La-Roche AG

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              General Electric Healthcare Life Sciences

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Thermo Fisher Scientific Inc.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Promega Corporation

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              New England Biolabs

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Enzo Biochem, Inc.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Vector Laboratories Inc.

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Merck KGaA.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Agilent Technologies

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Report Details

  • Report Code:36661
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:December 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers